Adam Taich - 24 Aug 2026 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Reporting relationship: Chief Financial Officer
Issuer ticker: TXG
Reported as of: 24 Aug 2026
Net transaction value: -$1,081,853
SEC form: 4
Accepted by SEC: 26 Aug 2026, 16:44:46 UTC
Prior SEC filing: 27 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Randy Wu, as Attorney-in-Fact for Adam Taich

Key filing fact

Adam Taich filed Form 4 for 10x Genomics, Inc. (TXG) on 26 Aug 2026.

Key facts

This page summarizes Adam Taich's Form 4 filing for 10x Genomics, Inc. (TXG).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Aug 2026, 16:44.

Change

Previous filing in this sequence was filed on 27 May 2026.
Current net transaction value: -$1,081,853.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001971187 Primary reporting owner

Taich Adam

Relationship: Chief Financial Officer
Address: 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON
Signature: /s/ Randy Wu, as Attorney-in-Fact for Adam Taich
Signature date: 26 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TXG transaction

Class A Common Stock

Sale

Transaction value: $1,081,853
Shares: -17,166
Change %: -4.5%
Price: $63.02
Shares after: 362,732
Date: 24 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.73, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.